
The Cox-Maze IV procedure (CMP-IV) is the only operation and technology with an FDA-approved indication for the surgical treatment of AF. In addition, the 3D printing technique enabled us to practice the Cox-maze IV procedure, given the patient's unique cardiac anatomy. The case herein is one of the first to report on adopting the CMP-IV procedure for situs inversus dextrocardia patients with complex valvuloplasty operation.

The patient had an uneventful recovery and was in sinus rhythm during a 12-month follow-up period using a 24-h Holter monitoring device. Mitral valvuloplasty, CMP-IV, and tricuspid annuloplasty were performed. A three-dimensional (3D) heart model printing device embedded with designated ablation lines was used for pre-operative planning. The patient was diagnosed with situs inversus dextrocardia, severe mitral regurgitation, and paroxysmal atrial fibrillation. Herein, we present the case of a 39-year-old male patient admitted to our cardiac center following progressive exertional dyspnea. The safety and efficacy of the Cox-Maze IV procedure (CMP-IV) for situs inversus dextrocardia patients with atrial fibrillation is yet to be determined.



The Alfa Laval plate heat exchangers will be installed in so called SECOOL applications, where seawater is used as a cooling media for different duties in the refinery. It was booked late June in the Gasketed Plate Heat Exchangers unit of the Energy Division, with deliveries scheduled for 2018. The order has a value of approximately SEK 90 million. Alfa Laval wins SEK 90 million energy-efficiency order in ChinaĪlfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has won an order to supply compact heat exchangers to a refinery in China.
